Introduce: company introducing:Zhejiang Warrant Pharmaceuitcal Co.,Ltd.is Located in the Binhai Industry Zone in Shaoxing, Zhejiang Province, Warrant Pharmaceuticals is a joint venture GMP-standarded manufacturer specializing in pharmaceutical raw materials and related chemical intermediates with total USD750.00 registered capitals and covering area 40,000sqm.
---Production capability for chemicals: five workshops with total 130 different kinds of reaction kettles(200-5000L capacity) to reach 800MTS annually.
---Production assurance: based strictly on GMP system to run production
---Facilities for environment protection: fully equipped and all products to be approved and evaluated by State Environment Protection Bureau.
---QC: with 1000sqm quality testing center, employees, testing instrument to conform strictly to the GMP standard.---Technical Support: R&D research center鈥淏eijing Warrant Tiancheng technology Co.,Ltd鈥漣nvested in Beijing specializing in new products and technology; Research lab in our plant focus on continued improving for present technology.
---Marketing:鈥淔ull Marketing鈥漷o be our management philosophy, credible quality,professional services,powerful technical supporting to satisfy our clients
--- employees :There are about 180 employees working at the site, over 70% of them are educated to be polytechnic or higher degree. 63 technical and research staffs among.
---Main products:
piperazine cycle: Hydroxyzine Hydrochloride,Eprazinone Hydrochloride, Ranolazine Hydrochloride, Urapidil Hydrochloride, Levodropropizine, Trazodone Hydrochloride, Cetirzine Hydrochloride ect.APIs and their intermediates, trying to be the production base of piperazine cyclization serial pharmaceutical raw materials in china.Quinolones: Pazufloxacin Mesilate, Prulifloxacin, Moxifloxacin ect.Apis and their intermediatesOthers: Pantoprazole Sodium(monohydrate,Sesquihydrate), Fosfomycin Trometamol, mycophenolate mofetil ect.We are willing to cooperate, achieve win-win solution and build a brilliant future hand in hand with friend.
